Investment Q&A

Q: Hi,
In Les' question submitted on Feb 17....you answered...."If we set aside risk parameters largely, we would consider these: BN, PNG, SHOP, CLS, ZDC, VNP, CSU, WSP, CNQ, CNR".
Was this the preference order to buy given the current climate of things? If not, could you please re-order with what you would buy first? Some are probably down (unwarranted?) more than others for various current reasons so those might be more attractive currently?

cheers,
Steve

Q: AGT Food and Ingredients was bought by FFH back in 2019, but has now announced it's intention to do an IPO. Why would FFH decide to let this go public just as relations with India seem to be thawing, opening up a huge market for AGT?

Q: Your thoughts on yesterday's earnings? Would you be comfortable adding? Is this a sell, buy, or hold?
Thank you
P

Q: Cold is having a good day today. whats going on with this stock? when is it ex div.
Thanks

Q: When does PNG next report and what is expected? What information in the release are you looking for that may influence the stock either up or down? Are your expectations different from consensus?

Q: Received my first dividend on this US listed stock in my US Rif. After looking at all the dividends in and deductions out, I calculate I'm paying approx. 47% with holding tax! 37% appears to be on the US side, 10% on the Canadian side. Sound about right to you? If so I'll be selling this right quick!
Also, do I now have to worry about filing US taxes?

Q: Hello Peter
while ALA, PEY, SU and CNQ are all doing well
Tou.ca seems to lag and is a disappointment
should I hold on to it or if I switch, which of the above is your favorite?
thanks
Michael

Q: Currently I do not own either of MDA or TSAT.

If I bought both would that be an overlap of similarity?

If yes which on would you choose with highest growth potential over the next 5 years?

Thanks

Sheldon

Q: I thought Goeasy reported. If so, may I have your comments on earnings please

Q: What would be your top pick for an ETF that tracks the S&P/TSX Composite Index?

Q: From Michael Burry.

Palantir’s accounts receivable (AR) is first up. The traditional metric for AR is Days Sales Outstanding (DSO), with higher DSO implying customers are taking their time to pay for Palantir’s services for one reason or another.

In 9 of the last 12 quarters, AR grew faster than revenue – a persistent pattern generally attached to nefarious tricks such as channel stuffing, aggressive revenue recognition, or extended payment terms used as sales concessions. For real subscription businesses, AR growth should track revenue growth closely. When AR is volatile or outgrows revenue, it means the company is booking sales faster than it is collecting cash.

Reason to sell or not, how big a deal is it?

Thank you.

Q: I must be missing something re MU. It is trading aa bit over 10x next years earnings, unless my sources are wrong. My question is why? They are building two new huge production facitilites in Boise, one in Japan and one in New York, because the supply can't keep up with demand. Their margins have increased from around 15% 18 months ago to 55% now, and they are projecting 66% in Q1.

I know they have two major (successful) competitors, but the demand is so strong, and the backlogs so long, I just don't see any major risk for at least the next 12-18 months. Am I wrong? So why is the PE so low?

Q: Hello,
Could you comment on most recent Roku earnings?
Many thanks

Stephane

Q: Hello team,

ALGN (up 46% in the past 3 months): Buy, hold, or sell? Why?

TWST (up 116% in the past 3 months): Buy, hold, or sell? Why?


Long holder of both and still deeply under water. So, I am wondering what is behind new signs of life!

As always, I appreciate your unemotional insight and guidance for us all!

Q: Hi 5i,

Would appreciate your thoughts on AMD moving forward.

I have held the stock for over 3 years and have done well but considering selling for other opportunities in the market at the moment.

Do you believe AMD has the potential to eventually catch up to Nvidia over the next few years? Can it keep capturing market share from intel?

Thank you,

Greg C.

Q: Good morning, Peter and Team,

Paul Krugman recently wrote the following in a Substack post:

'And the damage from the assault on vaccines continues to widen. Last week the Food and Drug Administration refused to review Moderna’s new mRNA-based flu vaccine. They didn’t reject it based on evidence; they wouldn’t even look at it, in line with RFK Jr.’s evidence-free, dogmatic assertion that mRNA technology, which gave us Covid vaccines, is useless and harmful. Pharmaceutical companies, understandably, are retreating from vaccine development.'

Is this another reason to avoid, or to at least reduce exposure to companies involved in vaccine development? For those of us with ETFs in the Health Care Sector, this becomes a daunting task.

Personally, I can't wait until the US midterms so that hopefully there can be some hope that this madness will end.

As always, thanks for your insights.

Q: I’d appreciate your advice regarding my Constellation Software holdings. I currently hold shares in my RRIF with an average cost $3,800 and in my TFSA $4,300.

Given the recent news, market sentiment, and the recent price movement, would you recommend averaging down at current levels, holding as is, or waiting for more clarity?

I’m focused primarily on long-term growth but want to be mindful of concentration risk and overall portfolio balance.

Thanks very much for your guidance.
Rick

Q: What are your top Canadian stock(s) if one wanted exposure to platinum?

Thanks for the great service!

Q: Hi Peter. Thanks for your great advice. I am overweight in equities and would like to diversify into fixed income ETFs. Please advise what your recommend as the best fixed income ETFs Canadian and US ETFS.

Thank you for your great service.

Peter

Q: Hi 5i guys. NXR (Nexus industrial reit) is now truly an industrial reit since they have sold almost all of their non-industrial properties. At the current price of around $7.77 per unit nexus has a yield slightly above 8 per cent!! In the past couple of years nxr's yield has been higher than their cash flow which is concerning, but the past quarter I believe their payout ratio was around 97 per cent (please confirm). They have a couple of new properties that should be contributing to cash flow and apparently they are releasing properties at much higher rates. Based on that I believe they should be able to continue with the generous yield since the payout ratio should slowly improve. What concerns me is the cost of their debt. They have to refinance a portion of the debt this year and next. The debt they are rolling over was at very low rates and the new rates are at least one per cent higher. Can your bloomberg terminal give an estimate of how much more interest NXR will have to pay on their new debt? If you can make a query as to whether the increasing of rent (and new property rent) will more than offset higher interest payments would be appreciated as well (I am not sure how sophisticated a Bloomberg terminal can be.) I was fortunate that last summer I rotated some tech into precious metal miner and now I want to pay it safe and reduce the PM miners with some income plays. NXR got on my radar. My only other reit exposure is a small position in Granite reit. Thanks for your help and I wish I had a Bloomberg terminal!!